VERU INC. Foreign Currency Transaction Gain (Loss), Realized
VERU INC. (VERU) reported Foreign Currency Transaction Gain (Loss), Realized of -$44.94 thousand for the 3-month period ending 2015-12-31, per its 10-Q filed 2016-02-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2016-02-02
- VERU INC. foreign currency transaction gain (loss), realized for the quarter ending 2015-12-31 was -$44.94K, a 315.60% decline year-over-year.
- VERU INC. foreign currency transaction gain (loss), realized for the quarter ending 2015-09-30 was $5.20K.
- VERU INC. foreign currency transaction gain (loss), realized for the quarter ending 2015-06-30 was $3.97K.
- VERU INC. foreign currency transaction gain (loss), realized for the quarter ending 2015-03-31 was $28.47K.
- VERU INC. foreign currency transaction gain (loss), realized for fiscal 2015 was $58.48K.
- VERU INC. foreign currency transaction gain (loss), realized for fiscal 2014 was -$83.84K.
- VERU INC. foreign currency transaction gain (loss), realized for fiscal 2013 was -$101.29K, a 168.31% decline from fiscal 2012.
- VERU INC. foreign currency transaction gain (loss), realized for fiscal 2012 was $148.27K.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 3 month | Foreign Currency Transaction Gain (Loss), Realized 6 month | Foreign Currency Transaction Gain (Loss), Realized 9 month | Foreign Currency Transaction Gain (Loss), Realized 12 month | Foreign Currency Transaction Gain (Loss), Realized 12 month as first filed |
|---|---|---|---|---|---|
| 2015-12-31 | -$44.94K 10-Q · filed 2016-02-02 | -$39.74K derived: sum of 2 quarters · filed 2016-02-02 | -$35.77K derived: sum of 3 quarters · filed 2016-02-02 | -$7.31K derived: sum of 4 quarters · filed 2016-02-02 | |
| 2015-09-30 | $5.20K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02 | $9.17K derived: sum of 2 quarters · filed 2015-12-02 | $37.64K derived: sum of 3 quarters · filed 2015-12-02 | $58.48K 10-K · filed 2015-12-02 | |
| 2015-06-30 | $3.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-07-30 | $32.43K derived: sum of 2 quarters · filed 2015-07-30 | $53.28K 10-Q · filed 2015-07-30 | $27.65K derived: sum of 4 quarters · filed 2016-02-02 | |
| 2015-03-31 | $28.47K 10-Q · filed 2015-04-30 | $49.31K 10-Q · filed 2015-04-30 | $23.68K derived: sum of 3 quarters · filed 2016-02-02 | $7.86K derived: sum of 4 quarters · filed 2016-02-02 | |
| 2014-12-31 | $20.85K 10-Q · filed 2016-02-02 | -$4.79K derived: sum of 2 quarters · filed 2016-02-02 | -$20.60K derived: sum of 3 quarters · filed 2016-02-02 | -$44.57K derived: sum of 4 quarters · filed 2016-02-02 | |
| 2014-09-30 | -$25.63K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02 | -$41.45K derived: sum of 2 quarters · filed 2015-12-02 | -$65.42K derived: sum of 3 quarters · filed 2015-12-02 | -$83.84K 10-K · filed 2015-12-02 | $83.84K 10-K · filed 2014-12-02 |
| 2014-06-30 | -$15.82K 10-Q · filed 2015-07-30 | -$39.79K derived: sum of 2 quarters · filed 2015-07-30 | -$58.21K 10-Q · filed 2015-07-30 | -$59.33K derived: sum of 4 quarters · filed 2015-12-02 | |
| 2014-03-31 | -$23.97K 10-Q · filed 2015-04-30 | -$42.39K 10-Q · filed 2015-04-30 | -$43.51K derived: sum of 3 quarters · filed 2015-12-02 | -$76.79K derived: sum of 4 quarters · filed 2015-12-02 | |
| 2013-12-31 | -$18.43K 10-Q · filed 2015-02-03 | -$19.54K derived: sum of 2 quarters · filed 2015-12-02 | -$52.82K derived: sum of 3 quarters · filed 2015-12-02 | -$82.45K derived: sum of 4 quarters · filed 2015-12-02 | |
| 2013-09-30 | -$1.11K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02 | -$34.40K derived: sum of 2 quarters · filed 2015-12-02 | -$64.02K derived: sum of 3 quarters · filed 2015-12-02 | -$101.29K 10-K · filed 2015-12-02 | |
| 2013-06-30 | -$33.28K 10-Q · filed 2014-07-31 | -$62.91K derived: sum of 2 quarters · filed 2014-07-31 | -$100.17K 10-Q · filed 2014-07-31 | ||
| 2013-03-31 | -$29.63K 10-Q · filed 2014-05-01 | -$66.89K 10-Q · filed 2014-05-01 | |||
| 2012-12-31 | -$37.27K 10-Q · filed 2014-02-03 | ||||
| 2012-09-30 | $148.27K 10-K · filed 2014-12-02 | -$148.27K 10-K · filed 2012-12-04 | |||
| 2011-09-30 | -$61.26K 10-K · filed 2013-12-03 | ||||
| 2010-09-30 | -$154.20K 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |